NYSEAMERICAN:CANF - Can-Fite BioPharma Ltd.
$3.15
 $-0.08
-2.51%
12:05PM EDT
2019-07-22
Can Fite Biofarma Ltd is an Israel-based biopharmaceutical company. The Company develops new treatments for autoimmune diseases and cancer. The Companys drugs are CF101 for Psoriasis treatment, RA treatment, for the treatment of Keratoconjunctictivitis Sicca, for the treatment of Glaucoma, among others; and CF102 for the treatment of liver diseases. The Company has a research infrastructure including research laboratories and animal house facilities run by the development team. Can Fite Biofarma Ltd signed distribution contracts with a Kwang Dong Pharmaceutical Co. allowing distribution of CF101 for arthritis in Korea and Seikagaku Corp. for distribution in Japan. The Company operates three subsidiaries, Ultratrend Ltd, EyeFite Ltd and OphathaliX Inc. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CANF     avg for
industry  
  avg for
sector  
42 stocks weight:  5. 02   217. 37   399. 45  
42 stocks rank:  4. 22 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  

quick ratio:  2. 75   5. 49   1. 88  
current ratio:  2. 75   5. 87   2. 36  

target price low:  3. 00   83. 44   114. 90  
target price avg:  3. 00   106. 20   137. 90  
target price high:  3. 00   132. 30   158. 97  
1-yr high:  24. 15   111. 86   142. 57  
last close:  3. 23   86. 79   125. 44  
50-day avg:  3. 40   86. 68   122. 63  
200-day avg:  13. 25   89. 22   121. 38  
1-yr low:  2. 77   69. 78   100. 51  
volume:  41. 16 K 2. 62 M 3. 43 M
50-day avg volume:  308. 55 K 3. 20 M 4. 16 M
200-day avg volume:  89. 64 K 2. 99 M 4. 75 M

1-day return:  -2. 09 % -1. 30 % -0. 99 %
this week return:  6. 63 % 0. 45 % -0. 20 %
12-wk return:  -63. 49 % 0. 94 % 4. 84 %
52-wk return:  -82. 81 % -1. 30 % 10. 55 %

enterprise value (EV):  1. 73 M 45. 10 B 122. 38 B
market cap:  10. 31 M 38. 96 B 108. 40 B
EBITDA:  -5. 52 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -0. 31   5. 38   11. 93  
enterprise/revenue (EV/R):  0. 49   57. 92   10. 21  
total revenue:  3. 49 M 9. 91 B 39. 98 B
total debt:  0. 00   10. 90 B 17. 48 B
net income (common):  -6. 68 M 2. 07 B 4. 05 B

shares outstanding:  3. 32 M 538. 09 M 1. 24 B
shares:  1. 11 M 548. 00 M 1. 22 B
shares short:  207. 14 K 10. 98 M 11. 87 M
shares short prior month:  86. 09 K 9. 32 M 12. 05 M
short ratio:  0. 33   5. 60   3. 34  
total cash/share:  2. 10   10. 98   9. 19  
total cash:  3. 21 M 5. 93 B 6. 10 B

book value:  2. 13   13. 35   27. 45  
price/book:  1. 52   4. 60   8. 78  
gross profits:  3. 82 M 7. 44 B 36. 13 B
operating margins:  -158. 79 % -308. 40 % -28. 55 %
EBITDA margins:  -158. 42 % 13. 17 % 23. 38 %
profit margins:  -191. 63 % 10. 44 % 14. 18 %
gross margins:  100. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -4. 80   2. 10   4. 23  
forward EPS:  -4. 05   3. 45   7. 10  
P/E:  -0. 67   1. 90   32. 10  
forward P/E:  -0. 80   6. 46   15. 47  
PE/G:  0. 01   0. 70   -0. 54  
growth:  -52. 70 % 265. 63 % 79. 11 %
earnings high:  -0. 15   0. 89   1. 68  
earnings avg:  -0. 15   0. 70   1. 57  
earnings low:  -0. 15   0. 46   1. 46  
revenue high:  2. 60 M 2. 57 B 11. 07 B
revenue avg:  2. 60 M 2. 51 B 10. 91 B
revenue low:  2. 60 M 2. 45 B 10. 73 B
return on assets:  -34. 67 % -2. 34 % 5. 28 %
return on equity:  -125. 20 % -90. 08 % 133. 53 %
revenue growth:  -52. 70 % 265. 25 % 73. 68 %
revenue/share:  2. 52   12. 72   60. 04  

beta (1yr vs S&P500):  0. 61   1. 27   0. 91  
sharpe (1yr):  -1. 71   0. 16   0. 77  

held % insiders:  0. 00 % 6. 06 % 3. 29 %
held % institutions:  21. 13 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CANF
.    101.453 =       101.453 :: --> INITIAL WEIGHT <--
.      - 4.8 =        96.653 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.962 =       189.635 :: P/E factor
.    x 2.209 =       418.897 :: PE/G factor
.    x 1.568 =       656.992 :: beta factor
.     x 0.76 =        499.56 :: sharpe factor
.    x 2.469 =      1233.237 :: current ratio factor
.    x 1.254 =      1545.945 :: quick ratio factor
.    x 1.903 =      2941.641 :: short ratio factor
.    x 1.009 =      2966.779 :: EV/R factor
.    x 1.008 =      2989.196 :: price-to-book factor
.                               --> PERFORMANCE <--
.    x 2.121 =      6339.466 :: sector+industry 1-year gains factor
.    x 1.009 =      6399.235 :: industry 12-weeks return factor
.    x 1.308 =      8369.486 :: industry 2-weeks return factor
.    x 0.999 =      8357.126 :: "drift" penalty 3 days ago
.    x 0.997 =      8328.233 :: "drift" penalty 4 days ago
.    / 2.084 =      3995.723 :: overall "drift" factor
.    x 0.623 =      2490.526 :: largest single-day jump factor
.    x 0.072 =       178.545 :: low price factor
.    x 0.452 =        80.752 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.641 =        51.736 :: forward EPS factor
.    x 0.869 =        44.981 :: forward P/E factor
.    x 1.185 =         53.29 :: industry recommendation factor
.    x 1.003 =        53.437 :: factor historical industry gain for week 29
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         2.704 :: reduced for readability
.    + 2.319 =         5.023 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      5.023 :: FINAL WEIGHT for NYSEAMERICAN:CANF


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org